RxDB
ICD-10-CM Codes Browse (Tabular) Diagnostic External Drug Neoplasm

T42.6X5S – Adverse effect of other antiepileptic and sedative-hypnotic drugs, sequela

Overview

Coding Notes

Active
Billable, valid for HIPAA-covered transactions

GEM Conversion to ICD-9 CM

Fs: 10111 – Late effect of adverse effect of drug, medicinal or biological substance
Fs: 10121 – Late effect of adverse effect of drug, medicinal or biological substance
Fs: 10112 – Other and unspecified anticonvulsants causing adverse effects in therapeutic use
Fs: 10122 – Other sedatives and hypnotics causing adverse effects in therapeutic use

MDC / MS-DRG Reference

OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITH MCC
OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITHOUT MCC

Sibling Codes

Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter
Adverse effect of other antiepileptic and sedative-hypnotic drugs, subsequent encounter

Parent Sibling Codes

Poisoning by other antiepileptic and sedative-hypnotic drugs, accidental (unintentional)
Poisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm
Poisoning by other antiepileptic and sedative-hypnotic drugs, assault
Poisoning by other antiepileptic and sedative-hypnotic drugs, undetermined
Adverse effect of other antiepileptic and sedative-hypnotic drugs
Underdosing of other antiepileptic and sedative-hypnotic drugs

Codes with Same Suffix

Traumatic subarachnoid hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela
Adverse effect of rifampicins, sequela
Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela
Adverse effect of alpha-adrenoreceptor antagonists, sequela
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
Adverse effect of antidiarrheal drugs, sequela
Adverse effect of antiasthmatics, sequela
Adverse effect of otorhinolaryngological drugs and preparations, sequela
Adverse effect of antidotes and chelating agents, sequela